Migraine therapy: Relationship between serotonergic contractile receptors in canine and rabbit saphenous veins to human cerebral and coronary arteries

Cephalalgia

Volumn 17, Issue 6, 1997, Pages 631-638

  Cohen, M L ^a   Johnson, K W ^a   Schenck, K W ^a   Phebus, L A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Canine saphenous veins; Human cerebral arteries; Human coronary arteries; Rabbit saphenous veins; Serotonin receptors

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ERGOTAMINE; MECOPROP; RIZATRIPTAN; SEROTONIN; SEROTONIN RECEPTOR; SUMATRIPTAN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; CONTROLLED STUDY; CORONARY ARTERY; DOG; HUMAN; HUMAN TISSUE; MIGRAINE; NONHUMAN; RABBIT; SAPHENOUS VEIN; VENOCONSTRICTION;

ANIMALS; CEREBRAL ARTERIES; CORONARY VESSELS; DOGS; DRUG EVALUATION, PRECLINICAL; HUMANS; MIGRAINE DISORDERS; RABBITS; RECEPTORS, SEROTONIN; SAPHENOUS VEIN; VASOCONSTRICTION;

EID: 0030806087     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1706631.x     Document Type: Article

References (45)

1. 1-like receptor in dog isolated saphenous vein. Br J Pharmacol 1988;94:1123
2. 1D agonists. Bio Med Chem Lett 1995;5:2649-54
3. 1D receptor agonist MK-462. Proc Third IUPHAR Meeting on Serotonin, Abst 98;1994
4. 1D receptors. J Med Chem 1995;38:3602-7
5. Graham JR, Wolff HG. Mechanism of migraine headache and action of egotamine tartrate. Arch Neurol Psychiat 1938;39: 737-63
6. 1-like receptors mediate contractions of the rabbit saphenous vein. Eur J Pharmacol 1990;191:375-82
7. 1Dβ' receptors. Eur J Pharmacol 1993; 242:75-82
8. Chester AH, Martin GR, Bodelsson M, Arneklo-Nobin B, Tadjkarimi S, Tornebrandt K, Yacoub MH. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990;24:932-7
9. 1-receptor agonist on central haemodynamics and the coronary circulation. J Clin Pharmacol 1992;34:541-6
10. Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor serotonin receptors. Cardiovasc Res 1993;27:2094-103
11. Ottervanger JP, Paalman JJA, Boxma GL, Stricker BHC. Transmural myocardial infarction with sumatriptan. Lancet 1993;341:1092
12. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993;44:242-6
13. 1D-like receptor. Life Sci 1994; 54:1671-80
14. 1D receptors. In: Olesen J, Moskowitz M, editors. Experimental headache models. Philadelphia: Lippincott-Raven Publishers, 1995:App 123-34
15. 1D receptor subtypes. Naunyn Schmiedeberg's Arch Pharmacol 1996;354:237-44
16. 1Dα receptor subtype expression in canine large coronary arteries and saphenous vein. Cardiovasc Res 1996;31:793-9
17. 2 receptors in serotonin-induced contraction of human isolated coronary arteries. Circulation 1994;90:1141-53
18. 2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br J Pharmacol 1996;117:283-92
19. Branchek TA, Zgombick JM, Kucharewicz SA, Gustafson EI, Durkin MM, Bard JA, Weinshank RL. Molecular perspectives on serotonin receptor subtypes in experimental models of migraine. Leeds Castle Workshop, 1995
20. Razzaque A, Longmore J, Hill RG. Differences in the effects of ketanserin and GR127935 on 5HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein. Eur J Pharmacol 1995;283:199-206
21. Martin GR, MacLenan SJ. Analysis of the 5HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria or receptor classification. Naunyn Schmiedebergs Arch Pharmacol 1990;342:111-9
22. 1D-like receptors in the saphenous veins and CNS of the dog and rabbit. Br J Pharmacol 1992;107:116P
23. 1D receptor subtype. Mol Pharmacol 1991;40:1036-42
24. 1Dβ receptors. FEBS Lett 1995;377:73-6
25. Villeneuve E, Blaise G, Sill JC, Guerard MJ, Buluran J, Girard D. Halothane 1.5 MAC, Isoflurane 1.5 MAC, and the contractile responses of coronary arteries obtained from human hearts. Anesth Analg 1991;72:454-61
26. Cocks TM, Kemp BK, Pruneau D, Angus JA. Comparison of contractile responses to 5-hydroxytryptamine (5HT) and sumatriptan in human isolated coronary artery: synergy with the thromboxane A-2 receptor agonist, U46619. Br J Pharmacol 1993;110:360-8
27. Forster C, Whalley ET. Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro. Naunyn Schmeidebergs Arch Pharmacol 1982;319:12-17
28. 1D binding sites. Br J Pharmacol 1991;102:227-33
29. Hardebo JE, Edvinsson L, Owman CH, Svendgaard N-a. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Neurology 1978;28:64-70
30. Jansen I, Olesen J, Edvinsson L. 5-hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993;147:141-50
31. Müller-Schweinitzer E. Vascular effects of ergot alkaloids: a study on human basilar arteries. Gen Pharmacol 1983;14:95-102
32. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989;96:434-40
33. 1-like receptor present on human isolated basilar artery. Neurotran Cerebro Funct 1989:229-32
34. Parsons AA, Motevalian M, Whalley ET. Contractile effects of 8-hydroxy-d(di-n-propylamino) tetralin and flexinoxan in human isolated basilar artery. Eur J Pharmacol 1991;202:17-23
35. Shibata S, Cheng JB, Murakami W. Reactivity of isolated human cerebral arteries to biogenic amines. Blood Vessels 1975;14:356-65
36. Tanishima T. Cerebral vasospasm: comparison of contractile responses in isolated human and canine basilar arteries. Brain Nerve 1983;35:323-9
37. Bax WA, Renzenbrink GJ, VanHeuven-Nolsen D, Thijssen EJ, Bos E, Saxen PR. 5HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol 1993;3:203-10
38. Borton M, Neliga M, Wood F, Derva P, Goggins K, Docherty JR. Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein. Br J Clin Pharmacol 1990;30:107S-8S
39. 1D receptor agonists sumatriptan and MK-462. Br J Pharmacol 1995;116:38
40. Chester AH, Allen SP, Tadjkarimi S, Yacoub MH. Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation 1993;87:874-80
41. 2 receptor activation. Eur J Pharmacol 1989;161:91-4
42. Ferro A, Longmore J, Hill RG, Brown MJ. A comparison of the contractile effects of 5-hydroxytryptamine, sumpatriptam and MK-462 on human coronary artery in vitro. Br J Clin Pharmacol 1995;40:245-51
43. Godfraind T, Finet M, Lima JS, Miller RC. Contractile activity of human coronary arteries and human myocardium in vitrc and their sensitivity to calcium entry blockade by nifedipine. J Pharmacol Exp Ther 1984;230:514-8
44. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperactive and contain stores of amines: a mechanism for coronary spasm. Science 1984:March 30:1435-7
45. Toda N, Okamura T. Comparison of the response to 5 carboxamidotryptamine and serotonin in isolated human monkey and dog coronary arteries. J Pharmacol Exp The 1990;253:676-82